The MHRA leads WP5, which delivers the project coordination function, including dissemination and communications. This Work Package has overall responsibility for establishing and running appropriate administrative, financial and project processes, as well as reporting on progress of the project to the IMI to ensure quality assurance of the project. An essential function of WP5 is to develop internal and external communications strategy, to support interaction between work packages, and to publicise the outcomes and findings of the project ensuring maximum impact.

Partners involved

  • MHRA
  • Novartis Pharma
  • Janssen Pharmaceutica
  • Bayer
  • UCB